新型CCR5拮抗剂——N-【1-{5-溴-2-[(4-氯苄基)氧基]苄基}-4-哌啶基】-N-乙基吡啶甲酰胺的合成

以5-溴水杨醛和4-氯苄氯为原料,通过消去、还原及溴化反应制得中间体4-溴-2-溴甲基-1-[(4-溴苄基)氧]苯(3);哌啶-4-酮经Boc保护、还原等4步反应制得中间体N-乙基-N-(4-哌啶基)吡啶甲酰胺(7);3与7通过消去反应合成了一种新型CCR5拮抗剂——N-【1-{5-溴-2-[(4-氯苄基)氧基]苄基}-4-哌啶基】-N-乙基吡啶甲酰胺,其结构经1H NMR,13C NMR和ESI-MS表征。     

4-(4-吗啉)哌啶盐酸盐的合成

4-甲酸乙酯哌啶与溴苄反应,再经酰胺化和氨化反应制得关键中间体4-氨基-1-苄基哌啶(5);5与2,2-二溴二乙醚经环化反应制得N-苄基-4-(4-吗啉)哌啶,再经成盐,加氢合成了4-(4-吗啉)哌啶盐酸盐(1,总收率24.9%),1的结构经1HNMR,IR和GC-MS确认。     

(2R,4S)-4-甲基-2-哌啶甲酸乙酯的合成

以S-(-)-α-苯乙胺为原料,经一锅法制得1-(1-苄基)-6-乙氧羰基-4-甲基-3,4-二氢哌啶(3),收率58.7%。以10%Pd/C为催化剂,3经催化氢化脱苄合成了4-甲基-2-哌啶甲酸乙酯(4),收率96%;4通过减压分馏得(2R,4S)-4,含量95%,其结构经1H NMR,IR和MS确证。     

(S)-(4-溴-2-甲苯)(3-甲基吗啉)甲酮的合成

以(S)-2-氨基丙醇和氯乙酰氯为起始原料,经酰化和环合反应制得(S)-5-甲基吗啉-3-酮（4）; 4经还原制得(S)-3-甲基吗啉(5); 5与4-溴-2-甲基苯甲酸酰化缩合合成了(S)-(4-溴2-甲基苯基)(3-甲基吗啉)-甲酮,总收率57%,其结构经¹H NMR 和 ¹³C NMR确证。     

合成宾达利的新方法

以邻氨基苯乙酮(2)为原料,经过连续的重氮化-还原-缩合反应序列制得3-甲基-1H-吲唑(3);3经(Boc)2O保护亚氨基后以NBS进行甲基溴代反应制得1-叔丁氧羰基-3-溴甲基-1H-吲唑(5);5与2-羟基异丁酸乙酯缩合得醚2-(1-叔丁氧羰基-1H-吲唑-3-基)甲氧基-2-甲基丙酸乙酯(6);6经HCl/乙酸乙酯溶液脱Boc保护制得关键中间体7;在叔丁醇钾存在下,7与溴苄缩合并水解合成了MCP-1抑制剂宾达利,总收率37.3%,其结构经1H NMR,13C NMR和MS确证。     

(S)-叔丁基吡咯烷-3-氨基甲酸酯的合成

以L-天冬氨酸为原料,经酯、氨基保护、酯还原、取代、关环和加氢脱苄基等6步反应高效合成了(S)-叔丁基吡咯烷-3-氨基甲酸酯,总收率20%,其结构经¹H NMR, ¹³C NMR和GC确证。     

新型麦角新碱中间体的合成

以2-甲基-3-硝基苯胺为起始原料,经Batcho-Leimgruber、酰化、还原、氧化、（R）-叔丁基亚磺酰胺的不对称诱导、烯烃闭环复分解反应等关键步骤,共经12步反应合成了麦角新碱中间体(S)-4-溴-3-｛［5-(甲氧基羰基)-1-甲基-1,2,3,6-四氢吡啶-2-基］甲基｝-1H-吲哚-1-甲酸叔丁酯,总收率7.2%,该路线涉及4个新化合物的合成,其结构经¹H NMR, ¹³C NMR和MS(ESI)表征。     

2-(取代哌嗪-1-甲基)-3-喹啉甲酸乙酯及其衍生物的合成、 表征及晶体结构

以邻硝基苯甲醛为起始原料, 经还原、Friedländer 缩合反应合成2-甲基-3-喹啉甲酸乙酯(2), 2经N-溴代丁二酰亚胺(NBS)溴代得到化合物3, 3再与N-取代哌嗪5a～5p 发生SN2亲核取代反应, 合成一系列2-(取代哌嗪-1-甲基)-3-喹啉甲酸乙酯及其衍生物6a～6p. 它们的结构通过元素分析, IR, 1H NMR, 13C NMR和MS进行了鉴定和表征, 并用X射线衍射法测定了化合物6n的晶体结构.     

(S)-(+)-2,2-二甲基环丙烷甲酰胺的不对称合成

以环己二胺作为手性源,与3,5-二叔丁基水杨醛经缩合反应制得Salen配体(R,R)-N,N'-二(3,5-二叔丁基水杨醛)-1,2-环己二胺(6);甘氨酸乙酯盐酸盐经重氮化和6与三氟甲烷磺酸亚铜催化的不对称环丙烷化反应制得(S)-(+)-2,2-二甲基环丙烷甲酸乙酯(9);9经水解、酰氯化和氨解反应合成了(S)-(+)-2,2-二甲基环丙烷甲酰胺,ee值82%,总收率55.4%,其结构经1H NMR和IR确证。     

3-溴-1-(3-氯-2-吡啶基)-1H-吡唑-5-甲酸的合成

以2,3-二氯吡啶为起始原料,通过水合肼亲核取代、马来酸二乙酯环合制得2-(3-氯-2-吡啶基)-5-氧-3-吡唑烷甲酸乙酯(5);5经苯磺酰氯酯化、溴化氢溴化制得3-溴-1-(3-氯-2-吡啶基)-4,5-二氢-1H-吡唑-5-甲酸乙酯(7);7经脱氢、水解合成了用于制备氯虫酰胺的关键中间体--3-溴-1-(3-氯-2-吡啶基)-1H-吡唑-5-甲酸,总收率39.5%,其结构经~1H NMR和MS确证.     

氮羟基邻苯二甲酰亚胺催化的α-紫罗兰酮的氧化反应

以分子氧（O₂）为氧化剂,在无溶剂条件下,研究了N-羟基邻苯二甲酰亚胺/乙酰丙酮亚钴(Ⅱ)体系对α-紫罗兰酮的催化氧化反应,分析了氧化产物,主要得到α-紫罗兰酮的烯丙位氧化产物5-氧代-α-紫罗兰酮,同时生成少量环氧α-紫罗兰酮及重排产物4-氧代-β-紫罗兰酮和环氧β-紫罗兰酮,提出了可能的反应机理,化合物的结构经IR, ¹H NMR, MS和EA等手段得以表征;为了提高5-氧代-α-紫罗兰酮的选择性和催化氧化反应的转化率,优化了催化氧化反应的工艺条件：当反应温度为70 ℃,氧气压力为1.0 MPa,N-羟基邻苯二甲酰亚胺和乙酰丙酮亚钴(Ⅱ)用量分别为α-紫罗兰酮的25%和1.0%,反应10 h,5-氧代-α-紫罗兰酮的产率达53.4%,反应转化率达95.0%以上,平行实验表明,实验重复性良好。     

Propylphosphonic anhydride(T3P~) catalyzed one-pot synthesis of α-aminonitriles

The Strecker reaction was performed via a one-pot three component condensation of hetero aromatic/aromatic aldehydes, secondary amines and trimetylsilyl cyanide in the presence of propylphosphonic anhydride(T3P~) to accomplish the corresponding a-aminonitriles. The main advantages of this method are very short reaction time and excellent yields.     

Ga(ClO4)3-catalyzed Reaction of 1,2-Diamines and α-Bromoketones: Synthesis of 2-Substituted Quinoxalines

Ga(ClO₄)₃-catalyzed reaction of 1,2-aryldiamines and α-bromoketones to afford 2-substituted quinoxa- lines in good yields is described. The reaction proceeded via grinding process with 10%(molar fraction) catalyst under solvent-free conditions at room temperature. For unsymmetrical o-phenylenediamines bearing electron-with- drawing groups, regio-selective quinoxalines were obtained.     

Facile synthesis of α-difluoromethyl α-propargylamines from CF2H-substituted N-tert-butanesulfinyl ketimines

Stereoselective approach for preparation ofα-difluoromethylα-propargylamines has been developed.1,2-Addition of lithium acetylides to diverse chiral difluoromethylated（S）-N-tert-butanesulfinyl ketimines by using Ti（OⁱPr）₄ as catalyst and THF as solvent afforded N-tert-butanesulfinamides in good to excellent yields（51-93%） and good diastereoselectivities（dr.85:15 to 93:7）.The N-tert -butanesulfinyl group can be readily cleaved under mild acidic condition（4 mol/L HCl in dioxane） to provide the correspondingα-difiuoromethylα-propargylamine in excellent yields（90-95%）.     

Synthese,NMR‐Spektren und Molekülstruktur von [(CH3)2Ga{μ‐P(H)Si(CH3)3}2Ga(CH3)2{μ‐P(Si(CH3)3)2}Ga(CH3)2]

Synthesis, NMR Spectra and Structure of [(CH₃)₂Ga{μ‐P(H)Si(CH₃)₃}₂Ga(CH₃)₂{μ‐P(Si(CH₃)₃)₂}Ga(CH₃)₂] The title compound has been prepared in good yield by the reaction of [Me₂GaOMe]₃ (Me = CH₃) with HP(SiMe₃)₂ in toluene (ratio 1 : 1,1) and purified by crystallization from pentane or toluene, respectively. This organogallium compound forms (Ga–P)₃ ring skeletons with one Ga–P(SiMe₃)₂–Ga and two Ga–P(H)SiMe₃–Ga bridges and crystallizes in the monoclinic space group C2/c. The known homologous Al‐compound is isotypic, both (M^III–P)₃ heterocycles have twist‐conformations, the ligands of the monophosphane bridges have trans arrangements.     

Dimerization of Incomplete Cubane-Type Mo3S4(DTP)3 Units Linked by Bridging α, ω-Dicarboxylate

Since the trinuclear molybdenum cluster compound Mo₃S₄(DTP)₃(μ-DTP)(L) (DTP=diethyldithiophosphate, L=loosely-coordinated ligand) was reported^[1],a large number of monomeric trinuclear molybdenum derivatives have been synthesized from it by its diverse substitution reactions^[2]. This reaction provides a useful route to design cluster complexes with specific functions. By the reaction with α, ω-dicarboxylates, we successfully synthesized the first oligomer containing two incomplete cubane-type[Mo₃S₄] cores formulated as[Mo₃S₄(DTP)₃(DMF)]₂[η²-μ-OOC(CH₂)₃COO-μ-η²]) whose molecule structure is as follows:     

Schwingungsspektren und Kraftkonstanten der Übergangsreihen OP(N(CH3)2)3 – OP(CH3)3 und SP(N(CH3)2)3 – SP(CH3)3

Vibrational Spectra and Force Constants of the Series OP(N(CH₃)₂)₃ – OP(CH₃)₃ and SP(N(CH₃)₂)₃ – SP(CH₃)₃ The vibrational spectra (IR and Raman) of the compounds of the title series are recorded and assigned to the normal vibrations. By a simplified force field the valence force constants are calculated and discussed. The results are compared with those of the NMR spectroscopy.     

聚碳酸乙烯撑酯与双端氨基聚乙二醇交联体系固定化酶载体的合成与表征

将聚碳酸乙烯撑酯(PVCA)与α,ω-双端氨基聚乙二醇(H₂N-PEG-NH₂)溶于DMF,于液蜡中进行交联反应制得亲水性固定化酶载体,将其与胰蛋白酶进行偶联反应制备了固定化胰蛋白酶.酶蛋白的比活力及其于载体上的结合量与反应条件有关,当w(PVCA)/w(H₂N-PEG-NH₂)为0.5时,二者均处于最高值.此固定化酶酶促反应的最适pH值和Km值均较之溶液酶有显著提高,但二者的最适酶促反应温度却相当一致.     

Synthesen und Strukturen neuer amido- und imidoverbrückter Cobaltcluster: [Li(THF)2]3[Co3(μ2-NHMes)3Cl6] (1), [Li(DME)3]2[Co18(μ4-NPh)3(μ3-NPh)12Cl3] (2), [Li(DME)3]2[Co6(μ4-NPh)(μ2-NPh)6(PPh2Et)2] (3) und [Li(THF)4][Co8(μ3-NPh)6(μ2-NPh)3(PPh3)2] (4)

Syntheses and Crystal Structures of new Amido- und Imidobridged Cobalt Clusters: [Li(THF)₂]₃[Co₃(μ₂-NHMes)₃Cl₆] (1), [Li(DME)₃]₂[Co₁₈(μ₄-NPh)₃(μ₃-NPh)₁₂Cl₃] (2), [Li(DME)₃]₂[Co₆(μ₄-NPh)(μ₂-NPh)₆(PPh₂Et)₂] (3), and [Li(THF)₄][Co₈(μ₃-NPh)₆(μ₂-NPh)₃(PPh₃)₂] (4) The reactions of cobalt(II)-chloride with the lithium-amides LiNHMes and Li₂NPh leads to an amido-bridged multinuclear complex [Li(THF)₂]₃[Co₃(μ₂-NHMes)₃Cl₆] ( 1 ) as well as to the imido-bridged cobalt cluster [Li(DME)₃]₂[Co₁₈(μ₄-NPh)₃(μ₃-NPh)₁₂Cl₃] ( 2 ). In the presence of tertiary phosphines two imido-bridged cobalt clusters [Li(DME)₃]₂[Co₆(μ₄-NPh)(μ₂-NPh)₆(PPh₂Et)₂] ( 3 ) and [Li(THF)₄][Co₈(μ₃-NPh)₆(μ₂-NPh)₃(PPh₃)₂] ( 4 ) result. The structures of 1 – 4 were characterized by X-ray single crystal structure analysis.